Mitsubishi Tanabe Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MTZPY and buy or sell other stocks, ETFs, and their options commission-free!About MTZPY
Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera.
CEOAkihiro Tsujimura, MBA
CEOAkihiro Tsujimura, MBA
Employees—
Employees—
HeadquartersOsaka, Osaka
HeadquartersOsaka, Osaka
Founded1933
Founded1933
Employees—
Employees—
MTZPY Key Statistics
Market cap10.43B
Market cap10.43B
Price-Earnings ratio5.47K
Price-Earnings ratio5.47K
Dividend yield—
Dividend yield—
Average volume38.96K
Average volume38.96K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$18.80
52 Week high$18.80
52 Week low$10.59
52 Week low$10.59
Stock Snapshot
With a market cap of 10.43B, Mitsubishi Tanabe Pharma(MTZPY) trades at $18.60. The stock has a price-to-earnings ratio of 5470.59.
On 2025-12-07, Mitsubishi Tanabe Pharma(MTZPY) stock opened at —, reached a high of —, and a low of —.
The Mitsubishi Tanabe Pharma(MTZPY)'s current trading volume is 0, compared to an average daily volume of 38.96K.
During the past year, Mitsubishi Tanabe Pharma(MTZPY) stock moved between $10.59 at its lowest and $18.80 at its peak.
During the past year, Mitsubishi Tanabe Pharma(MTZPY) stock moved between $10.59 at its lowest and $18.80 at its peak.